Heterocyclic inhibitors of CBP / EP 300 and their use in the treatment of cancer

摘要

The present invention relates to compounds of formula (I) and formula (II) and salts thereof and compositions and uses thereof. The compounds are useful as inhibitors of CBP and / or EP300. Pharmaceutical compositions comprising a compound of Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof, and various CBP and / or EP300 mediated disorders (eg, cancer, inflammatory disorders, and autoimmunity Also included are methods of using such compounds and salts in the treatment of diseases.